Track the Tatva Chintan Pharma Chem Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Tatva Chintan Pharma Chem Limited has recorded 7 public disclosures. Market capitalisation: €40bn. The latest transaction was filed on 9 February 2026 (Purchase). Among the most active insiders: Ajay Mansukhlal Patel. Every trade is free.
7
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€13m
6 ops.
Sell Volume
10Σ signal
Buys n/a€13m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,450 of 28,857 companies
43.2
score / 100
Value
25
Quality
62
FCF yld-2.1%
Earn yld1.1%
EV/EBITDA42.6x
ROE5.5%
Gross mgn56%
Net mgn8.3%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
233,766 shares@ ₹1,639.6044100.0% of flowEquity SharesSEBI:c376c5d5912e7714336a00da177d2ee4134b9e42
7 of 7 declarations
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited is a company specializing in the manufacture of chemical products for the pharmaceutical industry. It is listed on the XBOM market.